Given these observations, the present study aimed to evaluate inflammatory cytokines (TNF-α, IL-6, IL-8), adipokines (adiponectin, leptin), and microRNAs (miR-155, miR-146a) as candidate biomarkers for disease stage and progression in T2D. This evidence concerns the gene CXCL8 and type 2 diabetes mellitus.